JENNIE BOYLE: Open Payments
NPI 1831592583 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 82 payments from 11 companies in 2025. Trend: 2023 $1,813 · 2024 $1,060 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $234 |
| ABBVIE INC. | 27 | $195 |
| Janssen Pharmaceuticals, Inc | 7 | $155 |
| Neurocrine BioSciences, Inc. | 6 | $141 |
| Alkermes, Inc. | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. | 6 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, AUSTEDO XR, INGREZZA, ARISTADA, SPRAVATO, COBENFY, INVEGA SUSTENNA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
